Controlled stimulant treatment of ADHD and comorbid Tourette's syndrome: effects of stimulant and dose
- PMID: 9136492
- DOI: 10.1097/00004583-199705000-00008
Controlled stimulant treatment of ADHD and comorbid Tourette's syndrome: effects of stimulant and dose
Abstract
Objective: To determine the effects of methylphenidate (MPH) and dextroamphetamine (DEX) on tic severity in boys with attention-deficit/hyperactivity disorder (ADHD) comorbid with Tourette's syndrome.
Method: A 9-week, placebo-controlled, double-blind crossover using a wide range of doses was completed by 20 subjects in three cohorts.
Results: Relatively high doses of MPH and DEX in the first cohort produced significant increases in tic severity which were sustained on higher doses of DEX but which attenuated on MPH. Overall, 14 of 20 subjects continued stimulant treatment for 1 to 3 years, generally in combination with other psychotropics. Stimulant-associated adverse effects, including tic exacerbations, were reversible in all cases.
Conclusion: A substantial minority of comorbid subjects had consistent worsening of tics on stimulants, although the majority experienced improvement in ADHD symptoms with acceptable effects on tics. MPH was better tolerated than DEX.
Similar articles
-
Methylphenidate treatment of attention-deficit hyperactivity disorder in boys with Tourette's syndrome.J Am Acad Child Adolesc Psychiatry. 1989 Jul;28(4):574-9; discussion 580-2. doi: 10.1097/00004583-198907000-00016. J Am Acad Child Adolesc Psychiatry. 1989. PMID: 2768152 Clinical Trial.
-
The treatment of attention-deficit hyperactivity disorder in Tourette's syndrome: a double-blind placebo-controlled study with clonidine and desipramine.Pediatrics. 1995 Jan;95(1):74-81. Pediatrics. 1995. PMID: 7770313 Clinical Trial.
-
The relationship between tourette syndrome, attention deficit hyperactivity disorder, and stimulant medication: a critical review.Semin Pediatr Neurol. 2005 Dec;12(4):217-21. doi: 10.1016/j.spen.2005.12.003. Semin Pediatr Neurol. 2005. PMID: 16780292 Review.
-
Do typical clinical doses of methylphenidate cause tics in children treated for attention-deficit hyperactivity disorder?J Am Acad Child Adolesc Psychiatry. 1999 Aug;38(8):944-51. doi: 10.1097/00004583-199908000-00009. J Am Acad Child Adolesc Psychiatry. 1999. PMID: 10434485 Clinical Trial.
-
Tourette's syndrome: are stimulants safe?Curr Neurol Neurosci Rep. 2003 Jul;3(4):285-8. doi: 10.1007/s11910-003-0004-2. Curr Neurol Neurosci Rep. 2003. PMID: 12930697 Review.
Cited by
-
Pharmacotherapy for ADHD in children and adolescents: A summary and overview of different European guidelines.Eur J Pediatr. 2024 Mar;183(3):1047-1056. doi: 10.1007/s00431-023-05370-w. Epub 2023 Dec 14. Eur J Pediatr. 2024. PMID: 38095716 Review.
-
Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD).Cochrane Database Syst Rev. 2023 Mar 27;3(3):CD009885. doi: 10.1002/14651858.CD009885.pub3. Cochrane Database Syst Rev. 2023. PMID: 36971690 Free PMC article. Review.
-
Viloxazine, a Non-stimulant Norepinephrine Reuptake Inhibitor, for the Treatment of Attention Deficit Hyperactivity Disorder: A 3 Year Update.Health Psychol Res. 2022 Jul 28;10(3):37018. doi: 10.52965/001c.37018. eCollection 2022. Health Psychol Res. 2022. PMID: 35910243 Free PMC article.
-
Stimulant Induced Movement Disorders in Attention Deficit Hyperactivity Disorder.Soa Chongsonyon Chongsin Uihak. 2022 Apr 1;33(2):27-34. doi: 10.5765/jkacap.210034. Soa Chongsonyon Chongsin Uihak. 2022. PMID: 35418800 Free PMC article. Review.
-
A Comprehensive Review of Tic Disorders in Children.J Clin Med. 2021 Jun 3;10(11):2479. doi: 10.3390/jcm10112479. J Clin Med. 2021. PMID: 34204991 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
